Deoxyeritadenine methyl ester

脱氧菇嘌甲酯

Report date: 2023/07/05 14:07:37
NME

Base Information

Drug NameDeoxyeritadenine methyl ester
Drug Alias NameDZ-2002DZ2002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionS-adenosyl-L-homocysteine hydrolase inhibitors
TargetsS-adenosyl-L-homocysteine hydrolase
Therapy Area/IndicationsPsoriasisLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsPsoriasisLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A